Description: ReMark's Global Consumer Study delivers 10 key insights to empower customers. Insurers can design products that meet customers' needs and enhance client experiences and add significant value to their business. At the same time with new products being launched seemingly continuously, it is important to take a step back and assess risk throughout the product management cycle.

Description: In discussing the contemporary reactions to this regulation, as well as how EU-based insurance firms adapted to the shift, this segment will invite us to question our assumptions on the role of gender-based pricing in the future of the industry. In the latter half of the presentation, we will delve into the challenges faced by LGBTQ+ individuals when accessing life, health, and auto insurance.

Description: This interactive webcast uses case studies and a new framework to show how retirement plans and practices can be fitted to best serve organizations’ missions and objectives, guided by data and analytics measuring their workforce impact.

Description: Understanding how to effectively adopt AI is critical to staying competitive. This session will guide you through the five stages of AI adoption, with a deep dive into two key stages: Operational Optimization and Collaborative AI Integration. You will learn how to harness AI to streamline operations and boost efficiency, while also exploring the nuances of integrating AI in decision-making to enhance outcomes through human-AI collaboration.If you are seeking practical insights on maximizing AI's benefits while maintaining human oversight, this session will provide the tools and strategies to help you do just that—ensuring that your AI adoption journey is both effective and aligned with your business goals.

Description: "The script is for a Medicare session by the Society of Actuaries, led by Danica Turner, which introduces how revenue works on Part D. It covers the various cash flows and subsidies that Part D plans receive, including direct subsidies, federal reinsurance, and low-income subsidies. The session also explains the different phases of coverage and the upcoming changes due to the Inflation Reduction Act in 2025. The goal is to provide a high-level understanding of the revenue and payment calculations for Part D plans.

Description: Session 4F: Clear as Mud - The Impact of Price Transparency

Description: This session is open to all, but targeted to pension actuaries looking to understand the mechanics of how PRT is priced by life insurance actuaries, as well as life insurance actuaries who wish to understand how the stream of expected benefit payments and Accrued Benefits Obligation is calculated by Retirement Actuaries. Pension Risk Transfer involves two distinct disciplines of the actuarial profession. To date, understanding the other side of Pension Risk Transfer has been limited. This session will attempt to clarify the mechanics of the other side of PRT and explain how an actuarial model consolidating the two separate sides can be built. Panelists will include a retirement consulting actuary who helps retirement plan sponsors bring their pension plans to market to purchase PRT, as well as an experienced life insurer who works to price PRT.

Description: A comprehensive webcast designed to bring together industry practitioners to discuss the current state of Model Risk Management (MRM) frameworks. This event will delve into the advancements in MRM, the challenges faced by professionals in the field, and emerging trends such as machine learning model validation that are set to shape the future of MRM. Engage with experts, share knowledge, and explore innovative solutions to enhance the effectiveness of your MRM framework.

Description: This session will address the risk management, reserving and capital issues associated with index-linked annuities including financial reporting considerations for FIAs and RILAs, benefits of combining VA and RILA hedging and reserving under VM-21, current and future challenges with FIA reserving under VM-22, potential capital redundancy for FIAs, RILA interim values under AG 54, NAIC economic scenario reform, asset modeling, fund mapping and more!

Description: The cell and gene therapy marketplace is quickly evolving and continues to grow as a risk concern for governments, health plans, stop loss insurers and reinsurers. In this webinar, we discuss currently approved tissue, cell and gene therapies, the near-term pipeline, uptake considerations, case management processes, plan document and contract considerations, risk mitigation processes and programs, and network considerations.